Fulgent Genetics Total Liabilities 2015-2025 | FLGT

Fulgent Genetics total liabilities from 2015 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Fulgent Genetics Annual Total Liabilities
(Millions of US $)
2024 $91
2023 $102
2022 $116
2021 $113
2020 $131
2019 $6
2018 $3
2017 $3
2016 $4
2015 $1
2014 $0
Fulgent Genetics Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $83
2024-12-31 $91
2024-09-30 $99
2024-06-30 $103
2024-03-31 $103
2023-12-31 $102
2023-09-30 $97
2023-06-30 $91
2023-03-31 $108
2022-12-31 $116
2022-09-30 $124
2022-06-30 $151
2022-03-31 $153
2021-12-31 $113
2021-09-30 $160
2021-06-30 $129
2021-03-31 $198
2020-12-31 $131
2020-09-30 $60
2020-06-30 $9
2020-03-31 $8
2019-12-31 $6
2019-09-30 $7
2019-06-30 $5
2019-03-31 $6
2018-12-31 $3
2018-09-30 $2
2018-06-30 $3
2018-03-31 $2
2017-12-31 $3
2017-09-30 $3
2017-06-30 $3
2017-03-31 $4
2016-12-31 $4
2016-09-30 $6
2016-06-30 $5
2016-03-31 $0
2015-12-31
2015-09-30 $0
2015-06-30 $0
2014-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.631B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.506B 58.15
Hims & Hers Health (HIMS) United States $12.660B 131.53
Tempus AI (TEM) United States $9.553B 0.00
IRhythm Technologies (IRTC) United States $4.485B 0.00
Inspire Medical Systems (INSP) United States $4.076B 63.69
Privia Health (PRVA) United States $2.775B 189.67
Enovis (ENOV) United States $1.788B 9.97
Clover Health Investments (CLOV) United States $1.598B 0.00
Schrodinger (SDGR) United States $1.586B 0.00
Phreesia (PHR) United States $1.457B 0.00
Omnicell (OMCL) United States $1.423B 25.10
Azenta (AZTA) United States $1.223B 56.85
10x Genomics (TXG) United States $1.173B 0.00
Claritev (CTEV) United States $0.632B 0.00
Butterfly Network (BFLY) United States $0.593B 0.00
Talkspace (TALK) United States $0.534B 159.50
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.384B 0.00
TruBridge (TBRG) United States $0.360B 797.67
Outset Medical (OM) United States $0.311B 0.00
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.125B 0.00
American Well (AMWL) United States $0.105B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.085B 3.26
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Precipio (PRPO) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00